Kura Oncology
KURA
182 hedge funds and large institutions have $474M invested in Kura Oncology in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 84 increasing their positions, 44 reducing their positions, and 29 closing their positions.
91% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 44
66% more call options, than puts
Call options by funds: $434K | Put options by funds: $261K
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 29
1% less funds holding
Funds holding: 183 → 182 (-1)
4.79% less ownership
Funds ownership: 99.59% → 94.8% (-4.8%)
11% less capital invested
Capital invested by funds: $531M → $474M (-$57.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.56M |
| 2 |
BlackRock
New York
|
+$7.92M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$6.76M |
| 4 |
Millennium Management
New York
|
+$4.97M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$26.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$7.73M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$5.23M |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$4.22M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$3.84M |
KURA Hedge Fund Activity: Q2 2025 in Review
182 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2025, worth a combined $474M — down 11% from $531M a quarter earlier.
Fund positioning in KURA was balanced in Q2 2025: 29 funds opened new positions, 29 closed out, 84 added to existing stakes and 44 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $9.56M. The largest seller was RA Capital Management, exiting entirely with an estimated $26.4M sold.
- 182 institutional investors held Kura Oncology (KURA) as of Q2 2025, down from 183 in Q1 2025.
- Funds reported $474M of Kura Oncology stock for Q2 2025, down 11% quarter-over-quarter.
- 29 funds opened new Kura Oncology positions in Q2 2025 and 29 closed out, a net change of 0 holders.
- The largest Kura Oncology buyer in Q2 2025 was EcoR1 Capital, an estimated $9.56M added.
- The largest Kura Oncology seller in Q2 2025 was RA Capital Management, an estimated $26.4M sold.
Based on aggregated 13F filings for Q2 2025.